Ron Martell

Insider Reports History

Entity
Individual
Location
Poniard Pharmaceuticals, Inc., 750 Battery Street, Suite 330, San Francisco, CA
Signature
/s/ Herb Cross, as Attorney-in-Fact for Ron Martell
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ron Martell:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Jasper Therapeutics, Inc. President, CEO and Director, Director Voting Common Stock 331K $215K $0.65 Oct 12, 2023 Direct
Jasper Therapeutics, Inc. President, CEO and Director, Director Performance Restricted Stock Units 20K Jun 10, 2024 Direct
Jasper Therapeutics, Inc. President, CEO and Director, Director Stock Option (right to buy) 10K Jun 10, 2024 Direct

Insider Reports Filed by Ron Martell

Symbol Company Period Transactions Value $ Form Type Date Filed Role
JSPR Jasper Therapeutics, Inc. Jun 10, 2024 2 $0 4 Jun 12, 2024 President, CEO and Director, Director
JSPR Jasper Therapeutics, Inc. Feb 15, 2024 1 $0 4 Feb 20, 2024 President, CEO and Director, Director
JSPR Jasper Therapeutics, Inc. Oct 12, 2023 1 -$74.4K 4 Oct 13, 2023 President, CEO & Director, Director
JSPR Jasper Therapeutics, Inc. Apr 12, 2023 1 -$128K 4 Apr 14, 2023 President, CEO and Director, Director
JSPR Jasper Therapeutics, Inc. Mar 17, 2023 1 $0 4 Mar 20, 2023 President, CEO and Director, Director
JSPR Jasper Therapeutics, Inc. Feb 2, 2023 1 $0 4 Feb 3, 2023 President, CEO & Director, Director
JSPR Jasper Therapeutics, Inc. Oct 12, 2022 1 $0 4 Oct 13, 2022 President, CEO and Director, Director
JSPR Jasper Therapeutics, Inc. Mar 21, 2022 1 $0 4 Mar 23, 2022 President, CEO and Director, Director
JSPR Jasper Therapeutics, Inc. Mar 15, 2022 0 $0 3 Mar 21, 2022 President, CEO and Director, Director